Staffing and the cost of clinical and hospital pharmacy services in United States hospitals

被引:27
作者
Bond, CA
Raehl, CL
Pitterle, ME
机构
[1] Texas Tech Univ, Dept Pharm Practice, Hlth Sci Ctr, Sch Pharm, Amarillo, TX 79106 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Dept Psychiat, Sch Pharm, Amarillo, TX USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Pharm Practice, Sch Med, Amarillo, TX USA
[4] Texas Tech Univ, Hlth Sci Ctr, Dept Psychiat, Sch Med, Amarillo, TX USA
[5] Univ Wisconsin, Dept Pharm, Madison, WI USA
来源
PHARMACOTHERAPY | 1999年 / 19卷 / 06期
关键词
D O I
10.1592/phco.19.9.767.31542
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A survey was mailed to pharmacy directors at all United States acute care medical-surgical hospitals that related to staffing and cost components of hospital pharmacies and clinical services. Cost information was evaluated as both unadjusted and adjusted for severity of illness using the Health Care Financing Administration's Medicare case mix index (CMI). Unadjusted drug costs/occupied bed/year were $13,350 +/- 6927, a 36% increase over 1992 and a 112% increase over 1989, with statistically significant differences observed by geographic region, hospital size, hospital ownership, and drug delivery system. Annual median pharmacist salary costs/patient associated with centrally based clinical pharmacy services were drug use evaluation $111, inservice education $20, drug information $117, poison information $24, and clinical research $35. Annual median pharmacist salary costs/patient associated with patient-specific clinical services were drug therapy monitoring $5, pharmacokinetic consultation $8, patient counseling $6, medical rounds $4, admission drug histories $7, and drug therapy protocol management (prescribing) $9. Drug costs continue to increase at double-digit rates. Substantial differences exist among various regions of the country with salary and specific cost components. Registered nursing staffing is increasing at twice the rate of pharmacists staffing increases.
引用
收藏
页码:767 / 781
页数:15
相关论文
共 54 条
[1]   USE OF CLINICAL PHARMACISTS TO REDUCE CEFAMANDOLE, CEFOXITIN, AND TICARCILLIN COSTS [J].
ABRAMOWITZ, PW ;
NOLD, EG ;
HATFIELD, SM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1982, 39 (07) :1176-1180
[2]  
*AM HOSP ACC, 1993, AM HOSP ASS ABR GUID
[3]  
*AM HOSP ASS, 1996, AM HOSP ASS ABR GUID
[4]  
*AM HOSP ASS, 1990, AM HOSP ASS ABR GUID
[5]   DEVELOPMENT OF CLINICAL AND ECONOMIC PROGNOSES FROM MEDICARE CLAIMS DATA [J].
ANDERSON, G ;
STEINBERG, EP ;
WHITTLE, J ;
POWE, NR ;
ANTEBI, S ;
HERBERT, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (07) :967-972
[6]   IMPROVING DRUG-THERAPY DECISIONS THROUGH EDUCATIONAL OUTREACH - A RANDOMIZED CONTROLLED TRIAL OF ACADEMICALLY BASED DETAILING [J].
AVORN, J ;
SOUMERAI, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1457-1463
[7]  
BARKER KN, 1986, HDB I PHARM PRACTICE, P325
[8]  
BERMAN RA, 1986, J MED EDUC, V61, P1
[9]   EFFECT OF PHARMACISTS ON HEALTH-CARE OUTCOMES IN HOSPITALIZED-PATIENTS [J].
BJORNSON, DC ;
HINER, WO ;
POTYK, RP ;
NELSON, BA ;
LOMBARDO, FA ;
MORTON, TA ;
LARSON, LV ;
MARTIN, BP ;
SIKORA, RG ;
CAMMARATA, FA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (09) :1875-1884
[10]  
BLACK BL, 1986, RESOURCE BOOK PROGR